 |
|
|
|
 |
| JUNE
24 ,
2009 | ISSUE NUMBER 100 VOL 6 |
Regulatory
FDA Warning Letters Raise More Questions Than Answers
A panel of FDA regulators came to the Drug Information Association’s annual meeting to talk about DTC initiatives, but instead got an earful about the 14 search ad warning letters released to pharma companies a few weeks back.
Technology
Bridging the Data Gap
Microsoft walks Pharm Exec through its plan to gather data from many different locations, ranging from previous studies to current trends, and relate that information to current trials.
Profile
Working Toward a Solution: An Interview with Neil de Crescenzo
Oracle’s Neil de Crescenzo took time out of his busy schedule to talk to Pharm Exec about the state of life science IT in the clinical trial space, the challenges facing industry with regard to standardization, and suggestions about how pharma can battle the rising costs of IT.
Strategy
Measuring the Value of KOL Interactions
Thought leaders are a critical component of a pharmaceutical company’s professional marketing and medical strategies. But companies face a real challenge in creating, maintaining, and leveraging those relationships while safely navigating logistical issues and regulatory waters.
FDA
Hamburg Addresses Drug Regulation and FDA Challenges
The new commissioner of the Food and Drug Administration is mapping plans for turning around an agency that has been demoralized and buffeted about in the press, and has lost the trust of the American people.
New Media
A Plea for Change at HCMA Conference
Pharma might be aTwitter about social media, but few companies are freeing their marketing teams to try new strategies to engage consumers and patients.
|
 |
|  Momenta Pharmaceuticals appointed Bruce L. Downey to its board of directors // VMS hired Andrea Heslin Smiley, senior vice president of strategic marketing and client services; Kerry Aubin, vice president of client services; Nancy Lonsinger, vice president of strategy and chief compliance officer; and Dana Ennis, vice president of sales and corporate development //Maverick Technologies hired Rob Gellings to head its advanced manufacturing solutions business//Oliver Bootz joins CSafe as vice president of business development //
Par Pharmaceuticals elected Thomas P. Rice to its board of directors// Hollis-Eden Pharmaceuticals appointed James M. Frincke president and CEO
// Oncothyreon appointed Scott Peterson to vice president of research and development //MedThink Communications won two awards at the 15th Annual Communicator Awards competition for its health care Web site designs: a consumer Web site on OsmoPrep for Salix Pharmaceuticals and a CME Web site on Parkinson's disease for Teva // Cadient Group was ranked second on the Philadelphia Business Journal’s list of the top full-service advertising agencies in the Greater Philadelphia region
|
Advertisment
Free Educational Webcast Comparative Effectiveness
With President Obama calling for a national agency for comparative effectiveness and Congress introducing a bill in 2008 to set the stage at the federal level, no one doubts that comparative effectiveness is coming to healthcare. Join Tommy Bramley, senior director for Xcenda, and Tracy Foster, president for Lash Group on Thursday, June 25 at 2:00 PM (EDT) as they present on what these changes will encompass, how they will impact access to medications and what manufacturers can do to prepare.
Register Free at
 pharmexec.com/effectiveness
|
June
25 The Unvarnished Truth about Comparative Effectiveness
2:00 PM EST
July
8 Clinical Study Data Integration - the Art and the Promise
11:00 AM EST |
|
June 17–19 American
2009 HCMA Conference, IN-AWE & Delta Awards, Newport, New Jersey
June 21–25 Drug Information Association 45th Annual Meeting, San Diego, CA
June
22–24 11th Annual
Design for Six Sigma Excelling in Product Development 2009,
Chicago, Illinois.
July
30–31 CBI’s
4th Clinical Supply Chain Management Conference,
Princeton, NJ
September
21–24 5th
Annual Process Excellence Week for the Service & Transactional
World, Chicago, IL
October
5–7 BioNetwork
2009: The 7th Annual Pharmaceutical-Biotech Partnering
Conference, Laguna Niguel, California |
|
|
|
 |
|
 |
|
 |
| How would you rate the pharmaceutical industry's efforts to keep patients on their treatment regiments? |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.To
ensure delivery to your Inbox, please add %%email.list%% to your
address book. If you need help doing this, click
here.
Advanstar
Communications provides certain customer contact data (such as customers'
names, addresses, phone numbers and e-mail addresses) to third parties
who wish to promote relevant products, services and other opportunities
which may be of interest to you. If you do not want Advanstar Communications
to make your contact information available to third parties for
marketing purposes, simply call (toll free) 1-866-529-2922 at any
time, or fax us at 1-218-740-6417. Outside the U.S., please phone
1-218-740-6395. Contact us by mail at Advanstar Communications Inc.,
131 West First St., Duluth, MN 55802-2065, USA. |
|
